RELMADA THERAPEUTICS, INC. Quarterly Preferred Stock, Shares Authorized from Q3 2012 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
Relmada Therapeutics, Inc. quarterly Preferred Stock, Shares Authorized history and growth rate from Q3 2012 to Q1 2024.
  • Relmada Therapeutics, Inc. Preferred Stock, Shares Authorized for the quarter ending March 31, 2024 was 200M shares, a 5614% increase year-over-year.
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 200M +197M +5614% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 200M 0 0% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 3.5M -197M -98.3% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 3.5M -197M -98.3% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 3.5M Mar 31, 2023 10-Q 2023-05-11
Q4 2022 200M 0 0% Dec 31, 2022 10-K 2024-03-19
Q3 2022 200M 0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 200M 0 0% Jun 30, 2022 10-Q 2022-08-11
Q4 2021 200M 0 0% Dec 31, 2021 10-K 2023-03-23
Q3 2021 200M 0 0% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 200M 0 0% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 200M 0 0% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 200M 0 0% Dec 31, 2020 10-Q 2021-11-12
Q3 2020 200M 0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 200M 0 0% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 200M 0 0% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 200M 0 0% Dec 31, 2019 10-K 2021-03-24
Q3 2019 200M 0 0% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 200M 0 0% Jun 30, 2019 10-K 2021-03-24
Q1 2019 200M 0 0% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 200M 0 0% Dec 31, 2018 10-Q 2019-02-13
Q3 2018 200M 0 0% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 200M 0 0% Jun 30, 2018 10-KT 2020-03-26
Q1 2018 200M 0 0% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 200M 0 0% Dec 31, 2017 10-Q 2018-02-12
Q3 2017 200M 0 0% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 200M 0 0% Jun 30, 2017 10-K 2018-09-28
Q1 2017 200M 0 0% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 200M 0 0% Dec 31, 2016 10-Q 2017-02-10
Q3 2016 200M 0 0% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 200M 0 0% Jun 30, 2016 10-K 2017-09-28
Q1 2016 200M 0 0% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 200M 0 0% Dec 31, 2015 10-Q 2016-02-05
Q3 2015 200M 0 0% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 200M 0 0% Jun 30, 2015 10-K 2016-09-09
Q1 2015 200M -300M -60% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 200M 0 0% Dec 31, 2014 10-Q 2015-02-13
Q3 2014 200M +190M +1900% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 200M +190M +1900% Jun 30, 2014 10-K 2015-09-11
Q1 2014 500M +490M +4900% Mar 31, 2014 8-K 2014-05-27
Q4 2013 200M -300M -60% Dec 31, 2013 10-KT 2014-09-09
Q3 2013 10M 0 0% Aug 31, 2013 10-Q 2014-04-15
Q2 2013 10M May 31, 2013 10-Q 2013-07-12
Q1 2013 10M Feb 28, 2013 10-Q 2013-05-03
Q4 2012 500M Dec 31, 2012 8-K 2014-05-27
Q3 2012 10M Aug 31, 2012 10-K 2013-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.